End-to-End Capacity Cenexi operates across multiple European sites with a development center for New Product Introduction, enabling end-to-end outsourcing from development to commercial-scale manufacturing. This positions Cenexi as a convenient one-stop partner for pharma companies looking to simplify supply chains and accelerate time to market, especially for sterile and cytotoxic products.

Sterile Excellence A strategic emphasis on strengthening sterile capabilities under new leadership creates a strong selling point for customers needing compliant sterile fill-finish and high containment manufacturing, with potential for high-value program engagement.

Innovation Partnerships Cenexi has a track record of collaboration on advanced delivery systems, including needle-free autoinjectors, indicating openness to device integration and combination product opportunities, making Cenexi a good fit for clients pursuing injectable therapies with device co-development.

EU Proximity The European footprint provides proximity to key markets and regulatory hubs, supporting localized development and manufacturing that reduces regulatory and logistics risk for EU customers.

Strategic Backing Significant scale and ongoing strategic investments, along with leadership changes, signal a stable, growing partner with potential for long-term outsourcing commitments and expanded programs across development and manufacturing.